Evidence map›Paper›PMID 36280138›Full record

ArticleThe journal of allergy and clinical immunology. In practice2023

Effect of an Asthma Exacerbation on Medication Adherence.

Peter J Cvietusa, Glenn K Goodrich, Jo Ann Shoup, Diane K King, Bruce G Bender

Abstract read
In one paragraph

Article in The journal of allergy and clinical immunology. In practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. An Overview of Adherence-What It Is and Why It Is Important.The journal of allergy and clinical immunology. In practice · 2024
    Review
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Peter J CvietusaInstitute for Health Research, Kaiser Permanente Colorado, Denver, Colo; Department of Asthma, Allergy, and Immunology, Permanente Medical Group, Denver, Colo. Electronic address: Peter.J.Cvietusa@kp.org.
Glenn K GoodrichInstitute for Health Research, Kaiser Permanente Colorado, Denver, Colo.
Jo Ann ShoupInstitute for Health Research, Kaiser Permanente Colorado, Denver, Colo.
Diane K KingCenter for Behavioral Health Research and Services, Institute of Social and Economic Research, University of Alaska Anchorage, Anchorage, Alaska.
Bruce G BenderCenter for Health Promotion, National Jewish Health, Denver, Colo.

Funding

The Breathewell Program to Improve Asthma OutcomesR01HL126125 · NHLBI · NATIONAL JEWISH HEALTH · PI BENDER, BRUCE GEORGE · 2015 to 2019
$3.3M
NHLBI NIH HHS R01 HL126125
6 · The paper itself

Abstract

backgroundFew studies have looked at the effect of an asthma exacerbation on asthma medication adherence.

objectiveTo measure asthma medication adherence in the 12 months after an asthma exacerbation and the influence of care type (specialist vs primary care provider) as well as social economic status on adherence.

methodsWe measured portion of days covered (PDC) during the 12 months before and after an exacerbation in a cohort of patients with asthma who were aged 18 years and older. Subanalyses looked at PDC in those who had more than one exacerbation after the sentinel exacerbation, by type of care received (primary care, allergist or pulmonologist, or no care) during both periods and by socioeconomic status (SES), defined as the lower quartile of annual income for the group.

resultsIn a cohort of 1,697 patients, PDC improved significantly (from 0.44 to 0.53; P < .001) after an asthma exacerbation. Improvement in PDC was even greater (from 0.45 to 0.57; P < .001) if they had more than one exacerbation after the sentinel exacerbation. Being seen by a specialist after the exacerbation but not before it, resulted in the greatest improvement in PDC (0.17 mean change). Patients not seen by a specialist either before the exacerbation or after had a mean change of just 0.07. Those with a lower SES had an overall lower PDC before the exacerbation (0.37 vs 0.43) but saw a similar improvement in the PDC compared with those in a higher SES (0.09 vs 0.10).

conclusionsAn asthma exacerbation is associated with a significant and sustained effect on medication adherence.

Indexed as

AsthmaHumansIncomeMedication AdherenceRetrospective StudiesSocial ClassSocioeconomic FactorsAsthma exacerbationsAsthma medication adherenceSpecialty care

Identifiers

PMID36280138
PMCPMC10942659

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.